Quarterly report · Q3

Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
MetricValuePeriodScopeSource row
Revenue¥3.41T2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥1.14T2022-10-01 → 2022-12-31dCons.Revenue IFRS
Revenue¥3.98T2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥2.90T2021-04-01 → 2021-12-31Cons.Revenue IFRS
Revenue¥1.02T2021-10-01 → 2021-12-31dCons.Revenue IFRS
Operating income¥48.6bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income−¥69.7bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Operating income¥218.2bn2021-04-01 → 2021-12-31Cons.Operating profit loss IFRS
Operating income¥65.1bn2021-10-01 → 2021-12-31dCons.Operating profit loss IFRS
Profit before tax¥39.2bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax−¥82.8bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Profit before tax¥290.4bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥208.2bn2021-04-01 → 2021-12-31Cons.Profit loss before tax IFRS
Profit before tax¥61.0bn2021-10-01 → 2021-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥17.0bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥56.9bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥177.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥122.1bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥37.0bn2021-10-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥44.8bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income−¥46.7bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Net income¥209.4bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥147.3bn2021-04-01 → 2021-12-31Cons.Profit loss IFRS
Net income¥45.3bn2021-10-01 → 2021-12-31dCons.Profit loss IFRS
Total assets¥5.86Tat 2022-12-31Cons.Assets IFRS
Total assets¥5.57Tat 2022-03-31Cons.Assets IFRS
Total assets¥5.46Tat 2021-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥3.96Tat 2022-12-31Cons.Liabilities IFRS
Total liabilities¥3.73Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥1.90Tat 2022-12-31Cons.Equity IFRS
Net assets / equity¥1.84Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥1.71Tat 2021-12-31Cons.Equity IFRS
Net assets / equity¥1.57Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥1.50Tat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.46Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.35Tat 2021-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥257.0bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥245.8bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥259.3bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥349.6bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥174.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥346.9bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥248.0bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥174.4bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥128.8bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥140.6bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥8.8bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥336.3bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥200.6bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥11.992022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥-40.022022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥124.682021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥85.952021-04-01 → 2021-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥26.012021-10-01 → 2021-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥11.552022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-40.022022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥115.032021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥79.062021-04-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥23.932021-10-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio25.5%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio26.2%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.7%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥309.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥162.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥147.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥11.4bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥230.7bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥230.7bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥9.7bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue2022-04-01 → 2022-12-31¥1.14T
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.10T
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥37.2bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentsegment profit2022-04-01 → 2022-12-31¥19.3bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue2022-04-01 → 2022-12-31¥332.0bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue external2022-04-01 → 2022-12-31¥331.6bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥416m
jpcrp040300-q3r_E00808-000Health Carereportable segmentsegment profit2022-04-01 → 2022-12-31¥18.5bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue2022-04-01 → 2022-12-31¥873.0bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue external2022-04-01 → 2022-12-31¥866.4bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥6.7bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentsegment profit2022-04-01 → 2022-12-31¥84.3bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥983.5bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥944.5bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥38.9bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥54.1bn
—segment totalrevenue2022-04-01 → 2022-12-31¥3.33T
—segment totalrevenue external2022-04-01 → 2022-12-31¥3.24T
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥83.2bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥176.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥3.64T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥3.41T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥230.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥187.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-12-31¥279.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-12-31¥130.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-12-31¥148.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-12-31¥10.3bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥223.8bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥223.8bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥10.8bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue2021-04-01 → 2021-12-31¥953.7bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue external2021-04-01 → 2021-12-31¥921.8bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥31.9bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentsegment profit2021-04-01 → 2021-12-31¥83.5bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue2021-04-01 → 2021-12-31¥312.4bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue external2021-04-01 → 2021-12-31¥312.1bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥247m
jpcrp040300-q3r_E00808-000Health Carereportable segmentsegment profit2021-04-01 → 2021-12-31¥4.6bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue2021-04-01 → 2021-12-31¥691.5bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue external2021-04-01 → 2021-12-31¥686.6bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥5.0bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentsegment profit2021-04-01 → 2021-12-31¥73.9bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue2021-04-01 → 2021-12-31¥887.4bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue external2021-04-01 → 2021-12-31¥848.9bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥38.5bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentsegment profit2021-04-01 → 2021-12-31¥57.5bn
—segment totalrevenue2021-04-01 → 2021-12-31¥2.84T
—segment totalrevenue external2021-04-01 → 2021-12-31¥2.77T
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥75.6bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥219.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥3.12T
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥2.90T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥223.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥229.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 925
ItemContextValueUnit
Total transactions with owners IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Total transactions with owners IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Total transactions with owners IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-1714000000JPY
Total transactions with owners IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-44699000000JPY
Total transactions with owners IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-21013000000JPY
Total transactions with owners IFRSCurrentYTDDuration-65712000000JPY
Equity IFRSCurrentQuarterInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember54464000000JPY
Equity IFRSCurrentQuarterInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember-JPY
Equity IFRSCurrentQuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember89951000000JPY
Equity IFRSCurrentQuarterInstant_EffectivePortionOfCashFlowHedgesIFRSMember5438000000JPY
Equity IFRSCurrentQuarterInstant_OtherComponentsOfEquityIFRSMember149853000000JPY
Equity IFRSCurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember1495314000000JPY
Equity IFRSCurrentQuarterInstant_NonControllingInterestsIFRSMember404761000000JPY
Equity IFRSCurrentQuarterInstant1900075000000JPY
Profit loss before tax IFRSPrior1YTDDuration208177000000JPY
Profit loss before tax IFRSCurrentYTDDuration39207000000JPY
Depreciation and amortization ope cf IFRSPrior1YTDDuration186623000000JPY
Depreciation and amortization ope cf IFRSCurrentYTDDuration202652000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSPrior1YTDDuration-13657000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSCurrentYTDDuration-9732000000JPY
Impairment losses reversal of impairment losses ope cf IFRSPrior1YTDDuration8007000000JPY
Impairment losses reversal of impairment losses ope cf IFRSCurrentYTDDuration88399000000JPY
Provision for loss on plant closure ope cf IFRSPrior1YTDDuration-JPY
Provision for loss on plant closure ope cf IFRSCurrentYTDDuration31214000000JPY
Loss gain on sale and retirement of fixed assets ope cf IFRSPrior1YTDDuration7219000000JPY
Loss gain on sale and retirement of fixed assets ope cf IFRSCurrentYTDDuration6288000000JPY
Provision for loss on litigation ope cf IFRSPrior1YTDDuration-JPY
Provision for loss on litigation ope cf IFRSCurrentYTDDuration3550000000JPY
Loss gain on sale of fixed assets ope cf IFRSPrior1YTDDuration-8701000000JPY
Loss gain on sale of fixed assets ope cf IFRSCurrentYTDDuration-6972000000JPY
Gain on reversal of environmental expenses ope cf IFRSPrior1YTDDuration-JPY
Gain on reversal of environmental expenses ope cf IFRSCurrentYTDDuration-2389000000JPY
Gain on sale of investments in subsidiaries and associates ope cf IFRSPrior1YTDDuration-1886000000JPY
Gain on sale of investments in subsidiaries and associates ope cf IFRSCurrentYTDDuration-2238000000JPY
Interest and dividend income ope cf IFRSPrior1YTDDuration-5631000000JPY
Interest and dividend income ope cf IFRSCurrentYTDDuration-10631000000JPY
Interest expenses ope cf IFRSPrior1YTDDuration15712000000JPY
Interest expenses ope cf IFRSCurrentYTDDuration20632000000JPY
Decrease increase in trade receivables ope cf IFRSPrior1YTDDuration-80397000000JPY
Decrease increase in trade receivables ope cf IFRSCurrentYTDDuration-38949000000JPY
Decrease increase in inventories ope cf IFRSPrior1YTDDuration-105917000000JPY
Decrease increase in inventories ope cf IFRSCurrentYTDDuration-106305000000JPY
Increase decrease in trade payables ope cf IFRSPrior1YTDDuration80321000000JPY
Increase decrease in trade payables ope cf IFRSCurrentYTDDuration35865000000JPY
Increase or decrease in retirement benefit asset or liability ope cf IFRSPrior1YTDDuration4022000000JPY
Increase or decrease in retirement benefit asset or liability ope cf IFRSCurrentYTDDuration2633000000JPY
Other changes in working capital ope cf IFRSPrior1YTDDuration1615000000JPY
Other changes in working capital ope cf IFRSCurrentYTDDuration23498000000JPY
Subtotal ope cf IFRSPrior1YTDDuration295507000000JPY
Subtotal ope cf IFRSCurrentYTDDuration276722000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2021-10-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass